cyanocobalamin and semaglutide together equivalent compound / Injection Switching from a compounded to – semaglutide cyanocobalamin 2.5 ml Semaglutide

Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes

Ashok Kumar Das, Rakesh Kumar Sahay, Manash Pratim Baruah, Mangesh Tiwaskar, Sambit Das, Sudip Chatterjee, Banshi Saboo, Ganapathi Bantwal, Saptarshi Bhattacharya, Gagan Priya, Manoj Chawla, Kiraninder Brar, Syed Abbas Raza, Azizul Hasan Aamir, Dina Shrestha, Noel Somasundaram, Prasad Katulanda, Faria Afsana, Shahjada Selim, Mohammad Wali Naseri, Ali Latheef and Manilka Sumanatilleke have nothing to disclose

Phytomedicine 21 (5)

M1-like macrophages amplify ferroptotic pressure through ferritinophagy-mediated release of labile Fe + , increased transferrin receptor (TfR1) expression, and restricted ferroportin activity, thereby enriching the tumor microenvironment (TME) with redox-active iron (71)

Addressing root causes: Unlike medications that simply lower blood sugar, weight loss addresses the excess weight that contributed to developing diabetes in the first place